Workflow
Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates
SEERSeer(SEER) ZACKS·2025-02-28 00:40

Company Performance - Seer, Inc. reported a quarterly loss of 0.34pershare,whichwasbetterthantheZacksConsensusEstimateofalossof0.34 per share, which was better than the Zacks Consensus Estimate of a loss of 0.40, but worse than the loss of 0.28persharefromayearago,indicatinga21.40.28 per share from a year ago, indicating a 21.4% increase in loss year-over-year [1] - The company posted revenues of 4 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 0.25%, but down from 4.44millioninthesamequarterlastyear[2]−Overthelastfourquarters,SeerhassurpassedconsensusEPSestimatestwotimesandtoppedconsensusrevenueestimatestwotimes[2]MarketComparison−Seershareshavelostapproximately1.34.44 million in the same quarter last year [2] - Over the last four quarters, Seer has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Market Comparison - Seer shares have lost approximately 1.3% since the beginning of the year, while the S&P 500 has gained 1.3%, indicating underperformance relative to the broader market [3] Future Outlook - The current consensus EPS estimate for the upcoming quarter is -0.38 on revenues of 3.89million,andforthecurrentfiscalyear,itis−3.89 million, and for the current fiscal year, it is -1.66 on revenues of $20.03 million [7] - The estimate revisions trend for Seer is mixed, resulting in a Zacks Rank 3 (Hold), suggesting that the shares are expected to perform in line with the market in the near future [6] Industry Context - The Medical - Biomedical and Genetics industry, to which Seer belongs, is currently in the top 28% of over 250 Zacks industries, indicating a favorable industry outlook [8]